Current status of ARV treatment interruption and intermittent therapy strategies
1 November 2002. Related: On the web.
On the web
Pathogenesis and epidemiology of metabolic abnormalities
1 November 2002. Related: On the web.
Management of morphologic changes during antiretroviral therapy: insights from etiology
1 November 2002. Related: On the web.
Entry inhibitors
1 November 2002. Related: On the web.
Mitochondrial toxicity
1 November 2002. Related: On the web.
HIV medicine after the Barcelona conference: interview with Howard Grossman MD
1 November 2002. Related: On the web.
Once-daily antiretroviral options
1 November 2002. Related: On the web.
ABC of psychological medicine: fatigue
13 October 2002. Related: On the web.
Initial antiretroviral therapy: further insights on when to start and what to use
13 October 2002. Related: On the web.
Antiretroviral therapy in treatment-experienced patients
13 October 2002. Related: On the web.
Update on lipodystrophy…or is it just lipoatrophy?
13 October 2002. Related: On the web.
Opportunistic infections and coinfections: focus on fungi and hepatitis
13 October 2002. Related: On the web.
XI International HIV Drug Resistance Workshop: basic principles and clinical implications; Seville, Spain July 2-5, 2002
13 October 2002. Related: On the web.
Time for T
13 October 2002. Related: On the web.
CD4 cell depletion in AIDS: models for novel therapies
13 October 2002. Related: On the web.
FRAM study and lipodystrophy: lipodystrophy study presented at Barcelona and an interview with the study author Carl Grunfeld
13 October 2002. Related: On the web.
Adherence research roundup from the International AIDS Conference
11 September 2002. Related: On the web.
Additional AIDS 2002 reports at thebody.com
11 September 2002. Related: On the web.
NATAP reports from AIDS 2002 Barcelona
11 September 2002. Related: On the web.
Monkey puzzles
11 September 2002. Related: On the web.
Diversity considerations in HIV-1 vaccine selection
11 September 2002. Related: On the web.
Confronting the limits of success
11 September 2002. Related: On the web.
Mycobacterium avium complex and atypical mycobacterial infections in the setting of HIV infection
11 September 2002. Related: On the web.
Anaemia, neutropenia, and thrombocytopenia: pathogenesis and evolving treatment options in HIV-positive patients
11 September 2002. Related: On the web.
‘Natural’ resistance to HIV: is the evidence good enough to design an effective vaccine?
11 September 2002. Related: On the web.
Insights into HIV-specific CD4+ T cell immunity
11 September 2002. Related: On the web.
Cytomegalovirus: update
11 September 2002. Related: On the web.
The switching spiral: a triumph of hope over benefit?
11 September 2002. Related: On the web.
Peripheral neuropathy
11 September 2002. Related: On the web.
The push for once-daily HAART: a call for caution
11 September 2002. Related: On the web.
Enhancing adherence to antiretrovirals: strategies and regimens
11 September 2002. Related: On the web.
High doses of riboflavin and thiamine may help in secondary prevention of hyperlactatemia
11 September 2002. Related: On the web.
HAART and prevention of HIV transmission
11 September 2002. Related: On the web.
Resolution of renal failure after initiation of HAART: three cases and a discussion of the literature, from The AIDS Reader
11 July 2002. Related: On the web.
Development of the dual-subtype feline immunodeficiency virus vaccine
11 July 2002. Related: On the web.
HLA leaves its footprints on HIV
11 July 2002. Related: On the web.
Exploiting pharmacokinetics to optimise antiretroviral therapy
11 July 2002. Related: On the web.
Highlights from the 23 May 2002 supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
11 July 2002. Related: On the web.
Rhabdomyolysis due to probable interaction between simvastatin and ritonavir
11 July 2002. Related: On the web.
Largely favourable outcome for HIV+ transplant recipients
11 July 2002. Related: On the web.
Fibrates and statins and glitazones (oh my!)
11 June 2002. Related: On the web.
Nutrition and immunity: you are what you eat
11 June 2002. Related: On the web.
The role of dietary supplements in HIV
11 June 2002. Related: On the web.
Using evidence to make nutrition decisions: a look at zinc
11 June 2002. Related: On the web.
Peripheral neuropathy
11 June 2002. Related: On the web.
A potent weapon in the battle against HIV: your own immune system
11 June 2002. Related: On the web.
Incorporating antiretroviral resistance testing into clinical practice
11 May 2002. Related: On the web.
Management of co-infection with HIV and TB
11 May 2002. Related: On the web.
Further Retroconference reports and data on the web
10 April 2002. Related: On the web.
Controlling PI resistance like a switch: MDR1 and p-glycoprotein
10 April 2002. Related: On the web.
How do proteins cause drug resistance?
10 April 2002. Related: On the web.
HE2000
10 April 2002. Related: On the web.
The Body launches major new feature section on HIV+ women
10 March 2002. Related: On the web.
The role of IL-10 in long-term non-progressors
10 March 2002. Related: On the web.
Therapeutic immunisation: a vaccine by any other name
10 March 2002. Related: On the web.
Immune-based therapies for HIV: a history
10 March 2002. Related: On the web.
IL-2: promiscuous cytokine or steady date
10 March 2002. Related: On the web.
Wondering aloud: theories of one (quasi) LTNP
10 March 2002. Related: On the web.
The immune system: behind the scenes
10 March 2002. Related: On the web.
Immune restoration: repairing the damage
10 March 2002. Related: On the web.
Additional reports from ICAAC 2001
9 January 2002. Related: On the web.
Double scourge: tuberculosis and HIV coinfection
9 January 2002. Related: On the web.
The road to eradication: is HAART hard enough?
9 January 2002. Related: On the web.
Review: treatment of chronic hepatitis
9 December 2001. Related: On the web.
The drug development pipeline
2 November 2001. Related: On the web.